Narcolepsy Without Cataplexy
📧 Sign up to get email alerts when something new happens for Narcolepsy Without Cataplexy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Clarithromycin Mechanisms in Hypersomnia Syndromes [Phase 2]
Phase 2 trial results on clarithromycin mechanisms in hypersomnia syndromes including narcolepsy without cataplexy and idiopathic hypersomni…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Narcolepsy Nightmare Study [NA]
Completed clinical trial results for Narcolepsy-related conditions; results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Clarithromycin Mechanisms in Hypersomnia Syndromes [Phase 2]
Phase 2 clinical trial examining clarithromycin mechanisms in hypersomnia syndromes has completed. The study enrolled individuals with narco…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period [Phase 3]
Phase 3 pediatric study assessing efficacy and safety of pitolisant in narcolepsy with and without cataplexy completed; results have been po…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Narcolepsy Nightmare Study [NA]
A completed clinical trial update for the Narcolepsy Nightmare Study (NA) reported status as completed, with listed narcolepsy-related condi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Awareness and Self-Compassion Enhancing Narcolepsy Treatment [NA]
A completed clinical trial investigating awareness and self-compassion as a treatment approach for narcolepsy (including with and without ca…
-
CLINICAL_TRIALS trial_result · 2023-03-13Clinical Trial Update: An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy [Phase 2]
Phase 2 open-label trial of mazindol extended release (NLS-2) in narcolepsy with and without cataplexy completed.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of BTD-001 in idiopathic hypersomnia and narcolepsy type 2 (narcolepsy without cataple…
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: Flumazenil for the Treatment of Primary Hypersomnia [Phase 1, Phase 2]
Phase 1/2 clinical trial of flumazenil for primary hypersomnia completed with results posted in 2013.